We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+11.79%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$121B
AUM Growth
+$23.8B
(+25%)
Cap. Flow
+$14B
Cap. Flow
% of AUM
11.54%
Top 10 Holdings %
Top 10 Hldgs %
11.79%
Holding
3,434
New
284
Increased
1,844
Reduced
1,127
Closed
142
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Monster Beverage
MNST
|
+$345M |
| 2 |
PNC Financial Services
PNC
|
+$325M |
| 3 |
Edison International
EIX
|
+$249M |
| 4 |
Veeva Systems
VEEV
|
+$241M |
| 5 |
Expedia Group
EXPE
|
+$239M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$300M |
| 2 |
Comcast
CMCSA
|
+$255M |
| 3 |
Airbnb
ABNB
|
+$201M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$177M |
| 5 |
Eli Lilly
LLY
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25% |
| 2 | Financials | 15.05% |
| 3 | Consumer Discretionary | 12.44% |
| 4 | Healthcare | 12.08% |
| 5 | Industrials | 11.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTNM
3176
Contineum Therapeutics
CTNM
$545M
| $99.9K | ﹤0.01% |
+25,156
| New | +$109K |
|
3177
TTEC Holdings
TTEC
$113M
| $99.4K | ﹤0.01% |
20,672
-169,571
| -89% | -$778K |
|
3178
Navitas Semiconductor
NVTS
$3.44B
| $99.3K | ﹤0.01% |
15,153
+5,134
| +51% | +$19.8K |
|
3179
Rimini Street
RMNI
$458M
| $99K | ﹤0.01% |
26,252
-10,108
| -28% | -$33.8K |
|
3180
Candel Therapeutics
CADL
$769M
| $97.5K | ﹤0.01% |
19,261
-1,757
| -8% | -$9.04K |
|
3181
Design Therapeutics
DSGN
$897M
| $96.8K | ﹤0.01% |
28,726
-3,014
| -9% | -$11.3K |
|
3182
4D Molecular Therapeutics
FDMT
$582M
| $96.7K | ﹤0.01% |
26,061
+11,721
| +82% | +$41.2K |
|
3183
1stdibs.com
DIBS
$153M
| $96.4K | ﹤0.01% |
+35,045
| New | +$90.8K |
|
3184
Alta Equipment Group
ALTG
$237M
| $95.9K | ﹤0.01% |
15,181
+3,659
| +32% | +$18.5K |
|
3185
Pyxis Oncology
PYXS
$243M
| $95.4K | ﹤0.01% |
86,763
+46,493
| +115% | +$52.4K |
|
3186
Townsquare Media
TSQ
$108M
| $95.2K | ﹤0.01% |
+12,033
| New | +$85.1K |
|
|
AGNT
3187
AGNT Inc
AGNT
$715M
| $94.7K | ﹤0.01% |
10,403
-7,988
| -43% | -$69.8K |
|
3188
IHS Holding
IHS
$2.79B
| $94K | ﹤0.01% |
16,906
-50
| -0.3% | -$269 |
|
3189
Lifecore Biomedical
LFCR
$176M
| $93K | ﹤0.01% |
+11,451
| New | +$77.2K |
|
3190
Acacia Research
ACTG
$465M
| $92.4K | ﹤0.01% |
25,813
+14,924
| +137% | +$51.4K |
|
|
CLPR
3191
Clipper Realty
CLPR
$47.2M
| $91.9K | ﹤0.01% |
25,044
+2,346
| +10% | +$8.97K |
|
3192
Arhaus
ARHS
$1.34B
| $91.8K | ﹤0.01% |
+10,592
| New | +$88.4K |
|
|
ZYXI
3193
DELISTED
Zynex
ZYXI
| $91.8K | ﹤0.01% |
+35,584
| New | +$80.5K |
|
3194
LanzaTech
LNZA
$70.1M
| $91.5K | ﹤0.01% |
3,375
+1,532
| +83% | +$37.6K |
|
3195
MacroGenics
MGNX
$259M
| $91.4K | ﹤0.01% |
75,529
-156,870
| -68% | -$228K |
|
3196
Allogene Therapeutics
ALLO
$725M
| $91.1K | ﹤0.01% |
80,624
+22,401
| +38% | +$29.8K |
|
|
APLT
3197
DELISTED
Applied Therapeutics
APLT
| $89.3K | ﹤0.01% |
286,915
-285,396
| -50% | -$110K |
|
3198
Santander
BSBR
$43.1B
| $87.9K | ﹤0.01% |
+16,121
| New | +$82.3K |
|
3199
Evolv Technologies
EVLV
$1.05B
| $87.5K | ﹤0.01% |
+14,020
| New | +$64.9K |
|
3200
Paysign
PAYS
$707M
| $86.8K | ﹤0.01% |
+12,062
| New | +$43.2K |
|
Similar funds
VGA
AQR Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, AQR Capital Management held 3,434 positions worth $121B, up 25% from $97.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
AQR Capital Management deployed $14B of net new capital in Q2 2025, opening 284 new positions and adding to 1,844 existing holdings. Its largest new stake was Reddit: 531,663 shares worth $80.1M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was ConocoPhillips, an estimated $300M trimmed.
- AQR Capital Management's largest Q2 2025 buy was Reddit: 531,663 shares worth $80.1M.
- AQR Capital Management added most to Monster Beverage in Q2 2025, an estimated $345M increase.
- AQR Capital Management's biggest Q2 2025 reduction was ConocoPhillips, cutting an estimated $300M.
- AQR Capital Management fully exited Discover Financial Services in Q2 2025, selling an estimated $36.3M.
- AQR Capital Management's ten largest holdings make up 12% of its $121B portfolio in Q2 2025.
- AQR Capital Management opened 284 new positions and closed 142 in Q2 2025.
- AQR Capital Management's portfolio value rose 25% quarter-over-quarter to $121B.
Based on AQR Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.